Position in RPRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$13,967,990
+$4,473,240 QoQ
Shares Held
249,117
+25.9% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#128
of 635 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $551,218,616 across 202 Biotechnology names. RPRX ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,967,990 | 249,117 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $9,494,750 | 197,931 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,439,001 | 114,881 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,797,010 | 107,625 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,908,689 | 52,975 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,152,359 | 69,141 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $609,816 | 23,905 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $757,153 | 26,764 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,188,179 | 45,058 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $876,204 | 28,851 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $576,519 | 20,524 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $414,780 | 15,283 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $579,080 | 18,838 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $668,068 | 18,542 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $298,692 | 7,558 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $397,581 | 9,895 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $383,909 | 9,132 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $270,031 | 6,931 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $307,642 | 7,720 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $284,984 | 5,694 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $830,882 | 19,750 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $431,269 | 8,883 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||